Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Yield10 Bioscience Inc (YTEN)

Yield10 Bioscience Inc (YTEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,712
  • Shares Outstanding, K 4,871
  • Annual Sales, $ 800 K
  • Annual Income, $ -10,210 K
  • 60-Month Beta 1.11
  • Price/Sales 37.68
  • Price/Cash Flow N/A
  • Price/Book 1.54
Trade YTEN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.63
  • Number of Estimates 1
  • High Estimate -0.63
  • Low Estimate -0.63
  • Prior Year -0.87
  • Growth Rate Est. (year over year) +27.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.50 +18.36%
on 09/13/21
7.00 -7.00%
on 08/30/21
+0.68 (+11.66%)
since 08/17/21
3-Month
5.50 +18.36%
on 09/13/21
10.03 -35.09%
on 06/28/21
-2.47 (-27.51%)
since 06/17/21
52-Week
5.20 +25.19%
on 10/29/20
23.49 -72.29%
on 02/11/21
-0.70 (-9.71%)
since 09/17/20

Most Recent Stories

More News
Yield10 Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a corporate presentation at the H.C. Wainwright 23 Annual...

YTEN : 6.51 (+5.34%)
Metabolix, Inc. (YTEN) Reports Q2 Loss, Lags Revenue Estimates

Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -20.75% and -17.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

YTEN : 6.51 (+5.34%)
Yield10 Bioscience Announces Second Quarter 2021 Financial Results

Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review

YTEN : 6.51 (+5.34%)
Will Metabolix, Inc. (YTEN) Report Negative Q2 Earnings? What You Should Know

Metabolix, Inc. (YTEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

YTEN : 6.51 (+5.34%)
Yield10 Bioscience to Announce Second Quarter 2021 Financial Results and Host a Conference Call on Wednesday, August 11, 2021

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its second quarter 2021 financial results and provide a corporate update on Wednesday,...

YTEN : 6.51 (+5.34%)
Yield10 Bioscience Begins 2021 Field Test and Seed Scale Up Program

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it has completed planting of its 2021 Field Test and Seed Scale Up program at all contracted sites in the United...

YTEN : 6.51 (+5.34%)
Yield10 Bioscience Announces Two New Hires as Camelina Business Plan Advances

--Dr. Munyikwa Appointed as Director of Regulatory Affairs--

YTEN : 6.51 (+5.34%)
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances Using Camelina Platform to Produce PHA Bioplastic at 2021 Synthetic Biology: Engineering, Evolution and Design Virtual Conference

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the 2021 Synthetic Biology: Engineering,...

YTEN : 6.51 (+5.34%)
Yield10 Bioscience to Present at the LD Virtual Invitational XI on June 9, 2021

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will give a corporate presentation...

YTEN : 6.51 (+5.34%)
Yield10 Bioscience Announces First Quarter 2021 Financial Results

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three months ended March 31, 2021.

YTEN : 6.51 (+5.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to enhance global food security. The company is working on new approaches, to improve fundamental elements of plant photosynthetic efficiency and optimizing...

See More

Key Turning Points

3rd Resistance Point 7.10
2nd Resistance Point 6.80
1st Resistance Point 6.66
Last Price 6.51
1st Support Level 6.22
2nd Support Level 5.92
3rd Support Level 5.78

See More

52-Week High 23.49
Fibonacci 61.8% 16.50
Fibonacci 50% 14.34
Fibonacci 38.2% 12.19
Last Price 6.51
52-Week Low 5.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar